A detailed history of Step Stone Group LP transactions in Hille Vax, Inc. stock. As of the latest transaction made, Step Stone Group LP holds 826,569 shares of HLVX stock, worth $1.55 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
826,569
Previous 826,569 -0.0%
Holding current value
$1.55 Million
Previous $12 Million 87.83%
% of portfolio
0.59%
Previous 2.72%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$10.35 - $17.11 $20 - $34
2 Added 0.0%
826,569 $13.3 Million
Q3 2023

Nov 13, 2023

BUY
$11.59 - $16.7 $1.74 Million - $2.5 Million
149,998 Added 22.17%
826,567 $11.1 Million
Q1 2023

May 15, 2023

BUY
$14.73 - $18.18 $29 - $36
2 Added 0.0%
676,569 $11.2 Million
Q2 2022

Aug 12, 2022

BUY
$8.7 - $20.18 $5.89 Million - $13.7 Million
676,567 New
676,567 $7.4 Million

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $62.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Step Stone Group LP Portfolio

Follow Step Stone Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Step Stone Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Step Stone Group LP with notifications on news.